Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does COMBIVENT Cause Chronic obstructive pulmonary disease? 30 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Chronic obstructive pulmonary disease have been filed in association with COMBIVENT. This represents 2.4% of all adverse event reports for COMBIVENT.

30
Reports of Chronic obstructive pulmonary disease with COMBIVENT
2.4%
of all COMBIVENT reports
4
Deaths
18
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From COMBIVENT?

Of the 30 reports, 4 (13.3%) resulted in death, 18 (60.0%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for COMBIVENT. However, 30 reports have been filed with the FAERS database.

What Other Side Effects Does COMBIVENT Cause?

Product quality issue (385) Off label use (311) Dyspnoea (262) Drug ineffective (257) Cough (107) Overdose (103) Prescribed overdose (73) Pneumonia (47) Drug prescribing error (39) Choking (33)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which COMBIVENT Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

COMBIVENT vs COMBIVIR COMBIVENT vs COMETRIQ COMBIVENT vs CONCERTA COMBIVENT vs CONESTAT ALFA COMBIVENT vs COPANLISIB

Related Pages

COMBIVENT Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease COMBIVENT Demographics